The detection of diseases at an early stage of development provides many benefits, such as timely and specific treatment with considerable cost savings and the ability to trace the cause of an illness. To support the progress of early diagnostics, VITO focuses on the development of diagnostic assays and technologies, and on the identification of new biomarkers. We do this in close collaboration with academic partners, health experts and the pharmaceutical and biotech industries.

Publications

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
Year: 
2018
Journal: 
JOURNAL OF EXTRACELLULAR VESICLES
Thery, C; Witwer, KW; Aikawa, E; Alcaraz, MJ; Anderson, JD; Andriantsitohaina, R; Antoniou, A; Arab, T; Archer, F; Atkin-Smith, GK; Ayre, DC; Bach, JM; Bachurski, D; Baharvand, H; Balaj, L; Baldacchino, S; Bauer, NN; Baxter, AA; Bebawy, M; Beckham, C; Zav
Cohort Profile: Pregnancy And Childhood Epigenetics (PACE) Consortium
Year: 
2018
Journal: 
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Felix, JF; Joubert, BR; Baccarelli, AA; Sharp, GC; Almqvist, C; Annesi-Maesano, I; Arshad, H; Baiz, N; Bakermans-Kranenburg, MJ; Bakulski, KM; Binder, EB; Bouchard, L; Breton, CV; Brunekreef, B; Brunst, KJ; Burchard, EG; Bustamante, M; Chatzi, L; Munthe-K

Pages